Therapy Area Lead, Allergy & Immunology
Blueprint Medicines - Cambridge, Massachusetts, us, 02140
Work at Blueprint Medicines
Overview
- View job
Overview
What minimum qualifications do we require? 15+ years of industry experience with 8+ years leading drug development programs BA/BS degree required
What additional qualifications will make you a stronger candidate? Advanced degree preferred (e.g., MBA, PharmD, PhD, MD, MPH, MS) Deep understanding of drug development, registration and pre-commercialization Allergy/Immunology development and/or commercialization experience strongly preferred Fully and consistently demonstrates strong communication skills across all levels and functions - able to succinctly summarize complex issues (verbally and in writing) to move team forward serving as a role model for others Fully and consistently demonstrates strategic prioritization - helping teams to pivot and manage competing priorities and changing needs in fast-paced environment - providing clarity of direction to the team An authentic leader who builds and maintains strong relationships and trust, with exceptional ability to influence key stakeholders at all levels in a matrix environment Ability to inspire, empower and motivate teams often without direct authority to cultivate high performance by creating a boundary-less environment that invites diverse perspectives, continual improvement, and opportunistic thinking Ability to attract, retain and develop talent, either as a manager, or a leader of a cross functional team A strong collaborator who communicates in an open, direct, and timely manner Strong strategic thinker and problem-solver able to anticipate challenges, identify and progress practical solutions to challenging clinical, manufacturing, regulatory, and commercial problems Flexibility and the ability to nimbly adapt to changing conditions Motivated by patient focus and personal commitment to high performance and results Possesses high integrity and exceptional work ethic Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism
Why Blueprint? At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators - the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success. This is the place where the extraordinary becomes reality, and you could be part of it. Patients are waiting. Are you ready to make the leap? Equity, Diversity, Inclusion and Affirmative Action At Blueprint Medicines, we foster a culture of equity, diversity and inclusion. A proud Equal Employment Opportunity and Affirmative Action employer, we consider all qualified applicants without regard to race, color, sex, gender identity or expression, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable law. We are also an E-Verify Employer. We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to TotalRewards@blueprintmedicines.com. For more information, please see ourEEO-AA Policy Statement, the E-Verify Participation Poster, the Right to Work Poster, and/or theEEO Know Your Rights Poster, as well as ourPay Transparency Statement. Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors. #LI-Hybrid #LI-AQ1